Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190023/S026

Navitor Transcatheter Aortic Valve

ABBOTT MEDICAL · Decision date Jul 29, 2025

FDA DECISIONP190023/S026

What did the FDA decide?

FDA records P190023/S026 as a supplement to PMA P190023, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 29, 2025.

FDA approval order statement

two changes to the EO sterilization of components, processing aids, and Jar Set Assemblies (JSAs) - an addition of a duplicate sterilization chamber at an existing sterilization site, and the addition of an alternate sterilization facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jul 29, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P190023/S026
Regulatory pathway
PMA supplement
Product code
NPT
Decision code
OK30
Decision date
Jul 29, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic valve, prosthesis, percutaneously delivered.

Product code
NPT
FDA device class
3

For the original device and its historical approval scope, see PMA P190023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P190023 · Original PMA

    Portico Transcatheter Aortic Valve Implantation System

  2. P190023/S026 received

    Application receipt date recorded by FDA.

  3. P190023/S026 · FDA decision

    30-Day Notice

  4. P190023/S027 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  5. P190023/S028 · Related supplement

    FlexNav Delivery System; Navitor Transcatheter Aortic Valves

  6. P190023/S031 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  7. P190023/S030 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  8. P190023/S032 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  9. P190023/S029 · Related supplement

    Navitor TAVI System with Vision Technology

  10. P190023/S034 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  11. P190023/S033 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

Timeline entries are records held by MedtechLedger for P190023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190023

Explore the linked device profile

Other records with product code NPT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records